Showing results (61-70 of 141) with videos related to
Sort By:
Pageof 15
Journal of Virology|December 6, 2019
Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1Victoria Wang, David A Davis, Claire Deleage, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisRio McLellan, Laura Kus, David A Davis, et al.Plos One|May 6, 2015
Next-Generation Sequencing Analysis Reveals Differential Expression Profiles of MiRNA-mRNA Target Pairs in KSHV-Infected CellsCoralie Viollet, David A Davis, Martin Reczko, et al.Journal of Neurochemistry|August 10, 2013
Urban air pollutants reduce synaptic function of CA1 neurons via an NMDA/NȮ pathway in vitroDavid A Davis, Garnik Akopian, John P Walsh, et al.Scientific Reports|July 18, 2023
Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomasHannah K Jaeger, David A Davis, Ashwin Nair, et al.Antimicrobial Agents and Chemotherapy|April 18, 2012
Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processingDavid A Davis, Erin E Soule, Katharine S Davidoff, et al.Biorxiv : the Preprint Server for Biology|June 26, 2025
Caspase Cleavage of Kaposi Sarcoma-Associated Herpesvirus Proteins: A role for K5 in Preventing Caspase-Mediated Cell Death during Lytic ReplicationYana Astter, David A Davis, Emma Treco, et al.Academic Medicine : Journal of the Association of American Medical Colleges|October 28, 2009
Is there a relationship between high-quality performance in major teaching hospitals and residents' knowledge of quality and patient safety?Susan K Pingleton, Bernard J Horak, David A Davis, et al.Journal of Virology|August 29, 2025
Caspase cleavage of Kaposi sarcoma-associated herpesvirus proteins: a role for K5 in preventing caspase-mediated cell death during lytic replicationDavid A Davis, Yana Astter, Emma N Treco, et al.Antimicrobial Agents and Chemotherapy|January 18, 2002
Oxidative modifications of kynostatin-272, a potent human immunodeficiency virus type 1 protease inhibitor: potential mechanism for altered activity in monocytes/macrophagesDavid A Davis, Elizabeth Read-Connole, Kara Pearson, et al.Pageof 15